1·None of the assessed respiratory pathogens were associated with the severity of asthma exacerbations, the researchers note.
研究者指出，呼吸道病原体与哮喘恶化的程度无关。
2·The primary outcome was death from any cause for the comparison between the combination regimen and placebo; the frequency of exacerbations, health status, and spirometric values were also assessed.
所记录的原始结果包括由比较联合给药组和安慰剂组所得各种原因引起的死亡，以及对恶化的频率、健康状况和肺活量检查数值。
3·Global Initiative for asthma guidelines were used to assess the severity of asthma exacerbations.
用全球哮喘防治创议的指导原则评估哮喘恶化的程度。
4·To evaluate the efficacy of hospital at home compared to hospital inpatient care in acute exacerbations of COPD.
评估“医院在家”相较于住院照护在治疗慢性阻塞性肺病急性恶化的效益。
5·A new study reveals that obese children with asthma are significantly more likely to be admitted to the hospital for acute asthma exacerbations than their non-obese counterparts.
一项新研究表明：肥胖哮喘儿童较那些非肥胖哮喘儿童更可能因哮喘急性恶化而住院。
1·Objective to observe the efficacy of inhaled atomized Houttuynia injection combined with Shengmai injection in treating patients with acute exacerbations of chronic bronchitis.
目的观察雾化吸入鱼腥草注射液配合生脉注射液治疗慢性支气管炎急性发作期的效果。
2·AIM: to evaluate the efficacy of inhaling atomized garlicin injection for assistant treating acute exacerbations of chronic bronchitis.
目的：探讨大蒜素注射液雾化吸入辅助治疗慢性支气管炎急性发作患者的效果与机制。
3·OBJECTIVE To compare the efficacy and safety of moxifloxacin with clarithromycin for the treatment of patients with acute bacterial exacerbations of chronic bronchitis(ABECB) in short course therapy.
目的：观察莫西沙星短疗程治疗慢性支气管炎细菌感染急性发作（ABECB）的临床疗效。